Is predicting metastatic phaeochromocytoma and paraganglioma still effective without methoxytyramine? - Authors' reply

Lancet Digit Health. 2024 Mar;6(3):e155. doi: 10.1016/S2589-7500(24)00018-9.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adrenal Gland Neoplasms* / pathology
  • Dopamine / analogs & derivatives*
  • Humans
  • Paraganglioma* / pathology
  • Pheochromocytoma* / pathology
  • Pheochromocytoma* / secondary

Substances

  • 3-methoxytyramine
  • Dopamine